# Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)

> **NCT03493165** · — · NO_LONGER_AVAILABLE · sponsor: **The University of Texas Health Science Center at San Antonio**

## Conditions studied

- Uterine Sarcoma

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT03493165
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03493165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03493165, "Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03493165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*